[1]
T. Goulart Appel and J. F. D. Oliveira Neto, “Impact of the use of botulinium toxin type A in the current treatment off chronic migraine in adults”, International Journal of Neurology, vol. 57, p. 54, Dec. 2023, doi: 10.62486/ijn202354.